CUE BIOPHARMA INC's ticker is CUE and the CUSIP is 22978P106. A total of 38 filers reported holding CUE BIOPHARMA INC in Q3 2018. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $29,000 | +26.1% | 2,000 | 0.0% | 0.01% | +16.7% |
| Q2 2021 | $23,000 | -4.2% | 2,000 | 0.0% | 0.01% | -14.3% |
| Q1 2021 | $24,000 | -4.0% | 2,000 | 0.0% | 0.01% | -12.5% |
| Q4 2020 | $25,000 | -16.7% | 2,000 | 0.0% | 0.01% | -33.3% |
| Q3 2020 | $30,000 | -38.8% | 2,000 | 0.0% | 0.01% | -42.9% |
| Q2 2020 | $49,000 | +75.0% | 2,000 | 0.0% | 0.02% | +50.0% |
| Q1 2020 | $28,000 | -12.5% | 2,000 | 0.0% | 0.01% | +55.6% |
| Q4 2019 | $32,000 | +88.2% | 2,000 | 0.0% | 0.01% | +80.0% |
| Q3 2019 | $17,000 | -5.6% | 2,000 | 0.0% | 0.01% | 0.0% |
| Q2 2019 | $18,000 | +20.0% | 2,000 | 0.0% | 0.01% | +25.0% |
| Q1 2019 | $15,000 | -21.1% | 2,000 | -50.0% | 0.00% | -33.3% |
| Q4 2018 | $19,000 | -73.6% | 4,000 | -50.0% | 0.01% | -76.9% |
| Q3 2018 | $72,000 | -24.2% | 8,000 | 0.0% | 0.03% | -27.8% |
| Q2 2018 | $95,000 | – | 8,000 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Prosight Management, LP | 1,510,282 | $7,370,000 | 4.76% |
| SANDERS MORRIS HARRIS LLC | 873,021 | $4,261,000 | 0.83% |
| P.A.W. CAPITAL CORP | 150,000 | $732,000 | 0.76% |
| Nantahala Capital Management | 2,244,359 | $10,952,000 | 0.48% |
| Bleichroeder LP | 552,000 | $2,694,000 | 0.48% |
| APOGEM CAPITAL LLC | 111,259 | $543,000 | 0.37% |
| Slate Path Capital LP | 1,483,619 | $7,240,000 | 0.37% |
| Robertson Stephens Wealth Management, LLC | 478,500 | $2,335,000 | 0.20% |
| CARLSON CAPITAL L P | 405,000 | $1,976,000 | 0.14% |
| Bridgefront Capital, LLC | 19,968 | $97,000 | 0.12% |